The long-term outcomes of four alternative treatment strategies for primary open-angle glaucoma

Keyphrases

• Primary Open-angle Glaucoma 100%
• Incremental Cost-effectiveness Ratio 100%
• Quality-adjusted Life Years 100%
• Alternative Treatment Strategies 100%
• Treatment Strategy 66%
• Cost-effectiveness 66%
• Life-years Gained 66%
• Prostaglandin Analogs 66%
• Treatment Effect 33%
• Monotherapy 33%
• Glaucoma 33%
• Cost Reduction 33%
• Years of Life Lost 33%
• Initial Treatment 33%
• Sensitivity Analysis 33%
• Usual Care 33%
• Societal Perspective 33%
• Parameter Estimation 33%
• Cost-effectiveness Analysis 33%
• Natural Course 33%
• Patient-level 33%
• Beta-blockers 33%
• Visual Field 33%
• Glaucoma Patients 33%
• Health Gains 33%
• QALYs Gained 33%
• Level Model 33%
• Discrete Event Simulation 33%
• Withholding Treatment 33%
• Visual Field Test 33%
• Effectiveness Outcomes 33%
• Health Loss 33%
• Target Pressure 33%
• Heterogeneous Cohorts 33%
• Low Intraocular Pressure 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Glaucoma 100%
• Open Angle Glaucoma 100%
• Prostaglandin Analogue 100%
• Clinical Study 50%
• Monotherapy 50%
• Beta Adrenergic Receptor Blocking Agent 50%

INIS

• cost 100%
• silicon carbides 50%
• patients 37%
• comparative evaluations 37%
• simulation 25%
• prostaglandins 25%
• testing 12%
• data 12%
• levels 12%
• gain 12%
• losses 12%
• sensitivity analysis 12%
• cost effectiveness analysis 12%